Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone

Abstract

In this cohort of patients with diabetes, short-term use of pioglitazone was not associated with an increased incidence of bladder cancer, but use for more than 2 years was weakly associated with increased risk.